Filing Details

Accession Number:
0001225208-21-009444
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-15 19:01:42
Reporting Period:
2021-06-11
Accepted Time:
2021-06-15 19:01:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1088856 Corcept Therapeutics Inc CORT Pharmaceutical Preparations (2834) 770487658
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201715 Jr Leonard G Baker 755 Page Mill Road, Suite A-200
Palo Alto CA 94304-1005
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-11 50,000 $21.53 1,046,838 No 4 P Direct
Common Stock Acquisiton 2021-06-11 100,000 $21.53 3,308,303 No 4 P Indirect By Ltd Partnership
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect By Ltd Partnership
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 955,055 Indirect By Trust
Footnotes
  1. These shares were previously held by the Reporting Person for the exclusive benefit of Sutter Hill Management Company, L.L.C. ("SHM"), pursuant to the policy of SHM, and the Reporting Person previously disclaimed beneficial ownership of such shares. For the purpose of Section 16, the purchase of these shares by the Reporting Person's Roth IRA constituted a purchase by the Reporting Person to the extent that it increased his pecuniary interest in such shares.
  2. The number of shares reported as directly held reflects the reduction of shares previously reported by the Reporting Person as held for the exclusive benefit of SHM, to the extent of the shares acquired by Saunders Holdings, L.P., as described in footnote.
  3. These shares were previously held by the Reporting Person for the exclusive benefit of Sutter Hill Management Company, L.L.C. ("SHM"), pursuant to the policy of SHM, and the Reporting Person previously disclaimed beneficial ownership of such shares. For the purpose of Section 16, the purchase of these shares by Saunders Holdings, L.P. constituted a purchase by the Reporting Person to the extent that it increased his pecuniary interest in such shares.
  4. Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
  5. Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.